Antares Pharma is the developer and manufacturer of the Medi-Jector VISION® Needle-Free Insulin Delivery System.
Formed in 2001 by the merger of a drug delivery and a specialty pharmaceutical company, Medi-Ject Corporation in the United States and Permatec in Switzerland, we work hard every day to develop innovative technologies for improving the administration of pharmaceutical products.
Today we distribute our needle-free injector systems in more than 20 countries and markets. The same technology is also used with human growth hormone through our pharmaceutical partners in most major regions of the world. We are headquartered in Exton, Pennsylvania, with subsidiaries performing research, development, manufacturing and product commercialization activities in Minneapolis, Minnesota and Basel, Switzerland.
For more information please visit our corporate website at www.antarespharma.com.
